Chloromycetin
Chloromycetin Price range: $ 52,00 through $ 242,00
Back to products
Cialis
Cialis Price range: $ 40,00 through $ 470,00

Chloroquine

Price range: $ 41,00 through $ 402,00

Chloroquine is a well-established medication primarily utilized for the prevention and treatment of malaria in regions where the disease is prevalent. It functions by inhibiting the growth of parasites within the red blood cells, providing an effective defense against various strains of the infection. In addition to its antimalarial properties, this medication is frequently used to manage chronic autoimmune conditions such as rheumatoid arthritis. It also plays a significant role in reducing inflammation and alleviating symptoms for patients living with systemic lupus erythematosus. With decades of clinical application, Chloroquine continues to be a reliable therapeutic choice for these specific health concerns.

Active substance: Chloroquine
SKU: Chloroquine Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Chloroquine – Patient Guide and Information Overview

Chloroquine belongs to a class of medications known as 4-aminoquinoline derivatives, which are primarily utilized for their antimalarial and amebicidal properties. In the United States, chloroquine is a prescription medication regulated by the Food and Drug Administration (FDA) and requires a valid prescription from a licensed healthcare provider.

This agent is indicated for both the treatment and prophylaxis of specific strains of malaria, as well as the management of extraintestinal amebiasis. Proper clinical oversight is mandatory when taking chloroquine due to its specific safety considerations and potential organ system risks.

Attribute Detail
Drug name Chloroquine (as Chloroquine phosphate)
Active ingredient Chloroquine phosphate
Therapeutic class Antimalarial / Amebicide (4-Aminoquinoline)
Dosage form Oral tablet
Route of administration Oral
Prescription status Prescription (Rx only)

Main uses

Chloroquine is FDA-approved for the treatment and prevention of uncomplicated malaria caused by susceptible strains of Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. Dosing regimens vary significantly depending on whether the medication is administered for acute treatment or routine prophylaxis in travelers visiting endemic regions. In addition to malaria, chloroquine is indicated for the treatment of extraintestinal amebiasis, primarily liver abscesses caused by Entamoeba histolytica.

Any use outside of these approved indications, such as off-label administration for rheumatoid arthritis or systemic lupus erythematosus, represents off-label use and must be explicitly evaluated and monitored by a qualified prescriber. Chloroquine is not effective against chloroquine-resistant strains of Plasmodium falciparum, which are prevalent in many global tropical zones.

How the drug works

The mechanism of action of chloroquine concentrates on interfering with the parasite’s metabolism inside host erythrocytes. During the erythrocytic stage of malaria, the parasite digests host hemoglobin to acquire essential amino acids, releasing toxic free heme (ferriprotoporphyrin IX) as a byproduct. Under normal conditions, the parasite polymerizes free heme into an insoluble, non-toxic crystalline compound known as hemozoin.

Chloroquine binds to toxic heme molecules, preventing their polymerization into hemozoin. The resulting accumulation of toxic unpolymerized heme disrupts membrane function and leads to auto-lysis of the parasite cell. In extraintestinal amebiasis, chloroquine concentrated in hepatic tissue acts as a direct trophozoiticide against Entamoeba histolytica.

Dosing schedule

The exact dosing schedule for chloroquine depends upon the underlying condition, patient weight, age, and renal function. For suppressive therapy (prophylaxis) of malaria in adults, administration typically begins two weeks prior to entering an endemic area, continues weekly on the exact same day of the week during exposure, and extends for four consecutive weeks after leaving the region. For acute malarial attacks, a specific loading dose followed by subsequent doses over a 48-hour period is standard practice.

For extraintestinal amebiasis, dosing regimens involve an intensive initial daily dose for several days followed by a reduced daily maintenance dose for two to three weeks, often combined with an intestinal amebicide. Patients must follow the exact regimen specified on their prescription label and should not alter doses independently.

How it’s absorbed and eliminated

Chloroquine is rapidly and almost completely absorbed from the gastrointestinal tract following oral administration. Peak plasma concentrations are typically reached within two to three hours after oral ingestion. The drug exhibits extensive tissue binding throughout the body, particularly accumulating in the liver, spleen, kidneys, lungs, and melanin-containing structures such as the eyes.

Metabolism occurs partially in the liver via cytochrome P450 enzymes into its primary active metabolite, desethylchloroquine. Excretion occurs predominantly through the kidneys, with a substantial portion of the parent drug excreted unchanged in urine. Due to extensive tissue binding and accumulation, the terminal elimination half-life of chloroquine is prolonged, ranging from several days to weeks or even months as the drug gradually desorbs from tissue reservoirs.

Compatibility with other medicines

Chloroquine possesses significant drug interaction potential that requires careful medication reconciliation prior to initiating therapy. Co-administration with antacids containing aluminum or magnesium hydroxide reduces the gastrointestinal absorption of chloroquine; therefore, administration of these agents should be separated by at least four hours. Concomitant use with drugs known to prolong the QT interval (such as certain antiarrhythmics, fluoroquinolones, and antipsychotics) increases the risk of serious ventricular arrhythmias.

Chloroquine can increase serum digoxin levels, heightening the potential for digitalis toxicity. Additionally, concurrent administration with cimetidine can inhibit chloroquine metabolism, increasing plasma levels, whereas chloroquine may decrease the antibody response to intradermal rabies vaccine. Always inform your clinician of all concurrent prescription products, OTC drugs, and dietary supplements.

Adverse reactions

Adverse reactions associated with chloroquine therapy range from mild, self-limiting symptoms to serious long-term toxicities. Commonly reported mild side effects include transient nausea, vomiting, abdominal cramps, diarrhea, headache, mild dizziness, and pruritus (itching), which is particularly common in dark-skinned individuals. Taking the medication with meals can help lessen gastrointestinal distress.

Serious adverse reactions include irreversible retinal damage (retinopathy) with long-term high-dose use, cardiac conduction disorders, QT prolongation, severe hypoglycemia, skeletal muscle weakness (myopathy), and blood dyscrasias such as aplastic anemia or agranulocytosis. Neuropsychiatric reactions, including psychosis, confusion, and personality changes, have also been reported. Any visual changes or unexplained muscular weakness warrant immediate medical evaluation.

Important precautions

Patients receiving prolonged chloroquine therapy must undergo baseline and periodic ophthalmologic examinations, including visual acuity and central visual field testing, due to the risk of irreversible macular toxicity. Caution is required in individuals with pre-existing hepatic impairment, renal disease, porphyria, or psoriasis, as chloroquine may precipitate severe acute attacks of these conditions. Individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency face an elevated risk of severe hemolytic anemia.

In pediatric populations, chloroquine is extremely toxic; accidental ingestion of even small doses can prove fatal. In pregnant women, chloroquine crosses the placenta; while approved for malaria prophylaxis during pregnancy when benefit outweighs risk, it should be prescribed cautiously under direct physician supervision. Elderly patients require monitoring for cardiac and renal function due to altered drug clearance.

What to avoid while taking it

While taking chloroquine, patients should avoid co-administering aluminum- or magnesium-containing antacids within four hours of their dose to prevent reduced drug absorption. Excessive alcohol consumption should be avoided, as both alcohol and chloroquine are metabolized by the liver, potentially increasing hepatic strain or exacerbating gastrointestinal side effects. Additionally, patients experiencing dizziness or visual disturbances should avoid driving, operating machinery, or performing hazardous tasks until their individual tolerance to the medication is confirmed.

If you skip a dose

If a dose of chloroquine is missed, it should be taken as soon as remembered, unless it is close to the time for the next scheduled dose. If the next scheduled dose is near, skip the missed dose and resume the regular dosing schedule. Patients should never double the dose or take extra medicine to make up for a missed dose, as chloroquine exhibits a narrow therapeutic index and acute toxicity can develop rapidly.

Storage and expiration

Chloroquine tablets should be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). Keep the medication in a tight, light-resistant container away from excessive moisture, heat, and direct light. It is critical to keep this drug stored in child-proof containers securely out of reach of children. Expired medications should be disposed of properly through pharmacy take-back programs or local waste guidelines.

What to ask your provider

Before initiating therapy with chloroquine, prepare specific questions for your healthcare provider to ensure safe usage. Key topics to discuss include: “How frequently do I need eye examinations while taking this drug?”, “Are any of my current heart or acid-reflux medications incompatible with chloroquine?”, “What symptoms of low blood sugar should I watch for?”, and “What is the exact weekly schedule I must follow for malaria prevention?” Discussing these points clarifies your treatment plan and safety protocols.

Common questions

How long does chloroquine stay in the body after stopping therapy?

Because chloroquine binds extensively to body tissues such as the liver and spleen, it is eliminated very slowly. The terminal clearance phase can extend over several weeks to months after completing a treatment or prophylactic course.

Is eye monitoring required for short-term malaria treatment?

Standard short-term courses for acute malaria or weekly prophylaxis lasting only a few weeks generally present a low risk of ocular toxicity. Routine baseline and periodic eye exams are primarily recommended for patients undergoing prolonged or high-dose long-term treatment schedules.

What happens if someone accidentally ingests an overdose of chloroquine?

Chloroquine overdose is dangerous and can rapidly become life-threatening, causing cardiac arrest, severe arrhythmias, and seizures within 1 to 2 hours. Immediate emergency medical attention (calling 911 or contacting a poison control center) is required if an accidental overdose occurs.

Can chloroquine cause low blood sugar levels?

Yes, chloroquine can induce severe hypoglycemia, even in patients who do not have diabetes. Patients experiencing cold sweats, tremors, rapid heartbeat, or confusion should check their blood glucose levels and seek medical advice promptly.

Can I stop taking chloroquine early if I feel better during malaria treatment?

No, completing the entire prescribed course is essential to ensure complete clearance of the parasite and to prevent relapse or drug resistance. Stopping therapy early can result in treatment failure.

In accordance with FDA requirements.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

250mg

,

500 mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία